Managed care pharmacy, socioeconomic assessments and drug adoption decisions (Q40886683)

24 September 2017

title

Managed care pharmacy, socioeconomic assessments and drug adoption decisions (English)

1 reference

24 September 2017

0 references

Lyles A

1

1 reference

24 September 2017

Luce BR

series ordinal

2

1 reference

24 September 2017

Rentz AM

series ordinal

3

1 reference

24 September 2017

language of work or name

English

0 references

publication date

1 August 1997

1 reference

Social Science and Medicine

24 September 2017

published in

1 reference

24 September 2017

volume

45

1 reference

24 September 2017

issue

4

1 reference

24 September 2017

page(s)

511-521

1 reference

Formularies in integrated health systems: Fallon Healthcare System.

24 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0277-9536%2896%2900392-9

7 January 2021

The use of technology assessment by hospitals, health maintenance organizations, and third-party payers in the United States

1 reference

https://api.crossref.org/works/10.1016%2FS0277-9536%2896%2900392-9

7 January 2021

The view from managed care pharmacy

1 reference

https://api.crossref.org/works/10.1016%2FS0277-9536%2896%2900392-9

7 January 2021

Cost-effectiveness considerations for managed care systems: treating depression in primary care

1 reference

https://api.crossref.org/works/10.1016%2FS0277-9536%2896%2900392-9

7 January 2021

Pharmacy factors that influence the success of integrated health care systems

1 reference

https://api.crossref.org/works/10.1016%2FS0277-9536%2896%2900392-9

7 January 2021

Formularies in integrated health systems: Sharp HealthCare

1 reference

https://api.crossref.org/works/10.1016%2FS0277-9536%2896%2900392-9

7 January 2021

Evaluation of pharmacoeconomic studies: utilization of a checklist.

1 reference

https://api.crossref.org/works/10.1016%2FS0277-9536%2896%2900392-9

7 January 2021

The formulary decision-making process in a health maintenance organisation setting.

1 reference

https://api.crossref.org/works/10.1016%2FS0277-9536%2896%2900392-9

7 January 2021

Effects of a limiting Medicaid drug-reimbursement benefits on the use of psychotropic agents and acute mental health services by patients with schizophrenia.

1 reference

https://api.crossref.org/works/10.1016%2FS0277-9536%2896%2900392-9

7 January 2021

Effects of Medicaid drug-payment limits on admission to hospitals and nursing homes

1 reference

https://api.crossref.org/works/10.1016%2FS0277-9536%2896%2900392-9

7 January 2021

Medication formularies in integrated systems

1 reference

https://api.crossref.org/works/10.1016%2FS0277-9536%2896%2900392-9

7 January 2021

Impact of managed care on prescription drug use.

1 reference

https://api.crossref.org/works/10.1016%2FS0277-9536%2896%2900392-9

7 January 2021

10.1016/S0277-9536(96)00392-9

Identifiers

DOI

1 reference

24 September 2017

1 reference